Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.45 EUR | +0.93% | +3.81% | -17.92% |
25/04 | Transcript : Nanobiotix S.A., Q4 2023 Earnings Call, Apr 25, 2024 | |
24/04 | Nanobiotix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 23.53M 25.16M 2.1B | Sales 2025 * | 38.34M 41M 3.42B | Capitalization | 257M 275M 22.9B |
---|---|---|---|---|---|
Net income 2024 * | -40M -42.77M -3.57B | Net income 2025 * | -28M -29.94M -2.5B | EV / Sales 2024 * | 11.9 x |
Net Debt 2024 * | 24.35M 26.04M 2.17B | Net cash position 2025 * | 52.9M 56.56M 4.72B | EV / Sales 2025 * | 5.32 x |
P/E ratio 2024 * |
-7.19
x | P/E ratio 2025 * |
-18.8
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.72% |
Latest transcript on Nanobiotix
1 day | +0.93% | ||
1 week | +3.81% | ||
Current month | -4.39% | ||
1 month | -5.55% | ||
3 months | -23.99% | ||
6 months | -6.68% | ||
Current year | -17.92% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Lévy
CEO | Chief Executive Officer | 53 | 04/03/04 |
Bart van Rhijn
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CHM | Chairman | 58 | 25/21/25 |
Enno Spillner
BRD | Director/Board Member | 55 | 18/14/18 |
Alain Herrera
BRD | Director/Board Member | 74 | 23/11/23 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 5.45 | +0.93% | 25,481 |
25/24/25 | 5.4 | -2.44% | 26,330 |
24/24/24 | 5.535 | -3.74% | 45,258 |
23/24/23 | 5.75 | +6.88% | 46,597 |
22/24/22 | 5.38 | +2.48% | 37,347 |
Real-time Euronext Paris, April 26, 2024 at 09:05 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.92% | 274M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NANO Stock